B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism

Journal of Experimental Medicine

Volumn 189, Issue 6, 1999, Pages 919-930

  Stremmel, C ^a   Greenfield, E A ^a,b   Howard, E ^a   Freeman, G J ^b   Kuchroo, V K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

B7 2; Immune suppression; Interleukin 10; Interleukin 4; T lymphoma

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOMA; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; FEMALE; IMMUNE TOLERANCE; INTERLEUKIN-4; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; THYMOMA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033559251     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.6.919     Document Type: Article

References (38)

1. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science. 248:1349-1356.
2. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
3. Mueller, D.L., M.J. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
4. Freeman, G.J., G.S. Gray, C.D. Gimmi, D.B. Lombard, L.J. Zhou, M. White, J.D. Fingeroth, J.G. Gribben, and L.M. Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625-631.
5. Azuma, M., D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 366:76-79.
6. Freeman, G.J., F. Borriello, R.J. Hodes, H. Reiser, J.G. Gribben, J.W. Ng, J. Kim, J.M. Goldberg, K. Hathcock, G. Laszlo, et al. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185-2192.
7. Rennert P., K. Furlong, C. Jellis, E. Greenfield, G.J. Freeman, Y. Ueda, B. Levin, C.H. June, and G.S. Gray. 1997. The IgV domain of human B7-2 (CD86) is sufficient to costimulate T lymphocytes and induce cytokine secretion. Int. Immunol. 9:805-813.
8. Boussiotis, V.A., J.G. Gribben, G.J. Freeman, and L.M. Nadler. 1994. Blockade of the CD28 costimulatory pathway: a means to induce tolerance. Curr. Opin. Immunol. 6:797-807.
9. Hathcock, K.S., G. Laszio, C. Pucillo, P. Linsley, and R.J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
10. Nabavi, N., G.J. Freeman, A. Gault, D. Godfrey, L.M. Nadler, and L.H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature. 360:266-268.
11. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD 28 receptor families. Immunol. Today. 15:321-331.
12. Freeman, G.J., J.G. Gribben, V.A. Boussiotis, J.W. Ng, V.A. Restivo, L.G. Lombard, G.S. Gray, and L.M. Nadler. 1993. Cloning of B7-2: a counter-receptor that costimulates human T cell proliferation. Science. 262:909-911.
13. Allison, J.P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414-419.
14. Harper, K., C. Balzano, E. Rouvier, M.G. Mattel, M.F. Luciani, and P. Goldstein. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1037-1044.
15. Chambers, C.A., M.F. Krummel, B. Boittel, A. Hurwitz, T.J. Sullivan, S. Fournier, D. Cassell, M. Brunner, and J.P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of immune T cell responses. Immunol. Rev. 153:27-46.
16. Linsley, P.S., J.L. Greene, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
17. Chen, L., S. Ashe, W.A. Brady, I. Hellström, K.E. Hellström, J.A. Ledbetter, P. McGowan, and P.S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA4. Cell. 71:1093-1102.
18. + T cells by B7-transfected melanoma cells. Science. 259:368-370.
19. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellström, and K.E. Hellström. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523-532.
20. Hodge, J.W., S. Abrams, J. Schlom, and J.A. Kantor. 1994. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54:5552-5555.
21. Yang, G., K.E. Hellström, I. Hellström, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA4 costimulatory molecules J. Immunol. 154:2794-2800.
22. Greenfield, E.A., E. Howard, T. Paradis, K. Nguyen, F. Benazzo, P. McLean, P. Höllsberg, G. Davis, D.A. Hafler, A.H. Sharpe, et al. 1997. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. J. Immunol. 158:2025-2034.
23. Matulonis, U., C. Dosiou, G. Freeman, C. Lamont, P. Mauch, L.M. Nadler, and J.D. Griffin. 1996. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol. 156: 1126-1131.
24. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465-472.
25. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
26. Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M. Bernstein, X.Y. Ke, P.D. Rennert, J.G. Gribben, G.S. Gray, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:523-532.
27. Lanier, L.L., S. O'Fallon, C. Somoza, J.H. Phillips, P.S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97-105.
28. Thompson, C.B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell. 81:979-982.
29. Nakajima, A., N. Watanabe, S. Yoshino, H. Yagita, K. Okumura, and M. Azuma. 1997. Requirement of CD28-CD86 costimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 9:637-644.
30. Denfield, R.W., A. Dietrich, C. Wuttig, E. Tanczos, J.M. Weiss, W. Vanscheidt, E. Schopf, and J.C. Simon. 1995. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated antitumor immunity. Int. J. Cancer. 62:259-265.
31. Leong, C.C., J.V. Marley, J. Loh, N. Milech, B.W.S. Robinson, and M.J. Garlepp. 1997. Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma. Int. J. Cancer. 71:476-482.
32. Linsley, P.S., J. Bradshaw, J. Greene, R. Peach, K.L. Bennett, and R.S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity. 4:535-543.
33. Brown, J.A., R.G. Titus, N. Nabavi, and L.H. Glimcher. 1996. Blockade of CD86 ameliorates Leishmania infection by down-regulating the Th2 response. J. Infect. Dis. 174:1303-1308.
34. Ghosh, P., K.L. Komschlies, M. Cippitelli, D.L. Longo, J. Ye, J. Subleski, A. Sica, H.A. Young, R.H. Wiltrout, and A.C. Ochoa. 1995. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. Natl. Cancer Inst. 87:1478-1483.
35. Rohrer, J.W., and J.H. Coggin, Jr. 1995. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J. Immunol. 155:5719-5727.
36. Wang, L., E. Goillot, and R.I. Tepper. 1994. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cellular Immunol. 159:152-169.
37. Höllsberg, P., C. Scholz, D.E. Anderson, E.A. Greenfield, V.K. Kuchroo, G.J. Freeman, and D.A. Hafler. 1997. Expression of a hypoglycosylated form of CD86 (37-2) on human T cells with altered binding properties to CD28 and CTLA4. J. Immunol. 159:4799-4805.
38. Borriello, F., J. Oliveros, G.J. Freeman, L.M. Nadler, and A.H. Sharpe. 1995. Differential expression of alternate mB7-2 transcripts. J. Immunol. 155:5490-5497.